November 18, 2008 - Stereotaxis Inc. this week launched its partnered magnetic irrigated catheter at centers in Europe, after its strong performance in the partner's recently concluded external evaluation.
During the external evaluation, clinicians at nine centers in Europe and Canada performed 92 procedures with the magnetic irrigated catheter, approximately 75 percent of which were complex left-sided procedures. Stereotaxis said the catheter exceeded all clinical end points tested during this evaluation period. Additionally, mean time to complete mapping and ablation was 20 percent below documented manual times, and the catheter demonstrated an exceptional safety profile.
"As one of the original evaluation sites for the magnetic irrigated catheter, we were among the first to see its clear clinical advantages," said Gerhard Hindricks, M.D., of Herzentrum Leipzig GmbH in Leipzig. "Having now performed additional cases since its re-introduction, we're delighted by its performance relative to navigation and lesion formation and we're very excited to participate in its commercial release."
Dr. Karl Heinz-Kuck from St. Georg Allgemeines Krankenhaus in Hamburg said, "Its superb maneuverability provides precise positioning even at sites difficult to reach within the heart, and together with the catheter's stability this led to a high success rate."
For more information: www.stereotaxis.com
May 21, 2024 
